Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 6,631

Document Document Title
WO/2007/082475A1
Novel ent-kaurene diterpene compound and its derivatives, their preparation methods and their use. ent-Kaurene diterpene in the present invention could be used as desired intermediates for preparing asymmetric organic compounds and medic...  
WO/2007/082703A1
The present invention relates to a solvent-derived, cocoa extract comprising between 25 and 65% by weight of polyphenols, and uses thereof for improving a beer production process and the resulting beer product. The invention further rela...  
WO/2007/080170A1
The invention relates to a crystalline form of 1´-(1-methylethyl)- 4´-[(2-fluoro-4- methoxyphenyl)methyl]-5´-methyl-1H-pyrazol-3´-O-β-D-gluco pyranoside, to a method for the preparation thereof, as well as to the use thereof for pre...  
WO/2004/100886A3
The present invention provides polynucleotides encoding NF-kB-associated polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypept...  
WO/2007/080507A2
The invention relates to processes for the preparation of anhydrous azithromycin. The invention also relates to a one-pot process for the preparation of azithromycin without isolation of intermediates. The invention also relates to pharm...  
WO/2007/077219A1
The present invention relates to stable amorphous 3-De[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L- ribohexopyranosy l)oxy]- 1 1 , 12-dideoxy-6-O-methy 1-3-oxo- 12,11 -[oxycarbonyl[[4-[4-(3-pyridinyl)- 1 H- imidazol-l-yl]butyl]imino]]erythro...  
WO/2007/036951A3
The present invention provides a process for the preparation of 6-O-methylerythromycin A Form II comprising treating 6-O-methylerythromycin A with organic acid selected form trifluoroacetic acid, para-toluene sulphonic acid, oxalic acid ...  
WO/2007/059307A3
Provided is telithromycin which melts at a range of 175 °C to 185 °C. Also provided are solid states of telithromycin and processes for the preparation thereof.  
WO/2007/072800A1
Disclosed is a photosensitizing compound represented by the formula (I): (I) wherein R1 represents a hydrogen atom, a C1-12 alkyl group or a C1-12 alkoxy group; R2 represents a C1-12 alkyl group or a C1-12 alkoxy group; R3, R4, R5, R6, R...  
WO/2007/069264A2
A method of testing the purity of a sample of Telithromycin or a pharmaceutical dosage form comprising Telithromycin, which method comprises assaying the said sample for the presence of compound A, B and D, wherein compound A is represen...  
WO/2007/039914A3
The present invention relates to novel polymorphs of Telithromycin designated as Form I, II and III and its process for preparation. Also it provides Telithromycin with at least 99% purity.  
WO/2007/069555A1
Disclosed is a compound represented by the general formula (1) below or a pharmaceutically acceptable salt thereof. Also disclosed are a process for producing such a compound or a pharmaceutically acceptable salt thereof, and a pharmaceu...  
WO/2007/044927A3
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO/2007/067281A2
A method for demethylating the 3'-dimethylamino group of erythromycin compounds.  
WO/2007/050375A3
CCR5 antagonists having the following core structure Formula (I) (AA) are claimed, for the treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic der...  
WO/2006/072334A3
The invention relates to a method for producing thiophene glycoside derivatives of general formula (I), wherein: Y represents hydrogen or alkyl; R1 represents alkyl, whereby hydrogen can be substituted by fluorine or aryl, and aryl can a...  
WO2007043710A9
Compounds represented by the general formula [I] (wherein each symbol is as defined in the description) or pharmacologically acceptable salts thereof; and pharmaceutical compositions containing the compounds or the salts as the active in...  
WO/2007/062468A1
Compounds having useful biological activity, particularly antioxidant and anti-inflammatory activity, derived from Centipeda cunninghamii, and biologically active derivatives thereof, pharmaceutical compositions comprising these compound...  
WO/2007/063335A2
The invention provides a salt of amphotericin B and meglumine in which the molar ratio of amphotericin B to meglumine is about 1:1.  
WO/2007/060686A1
The present invention provides novel loganin analogues of formula (I) and a process for the preparation thereof. The present invention further provides the use of lridoid glycoside loganin isolated from the fruit pulp of Strychnos nux-vo...  
WO2006056297A9
The invention relates to complexes of specific flavonoid derivatives of formula (I), wherein R1 and R2 are selected among H and OR11, OR11 independently representing OH, straight-chain or branched C1 to C20 alkyloxy groups, straight-chai...  
WO/2007/060618A2
The present invention provides macrolide derivatives, which can be used as antibacterial agents. Compounds described herein can be used for treating or preventing conditions caused by or contributed to by gram-positive, gram-negative or ...  
WO/2007/060518A2
Provided herein are ketolide derivatives, which can be used as antibacterial agents. Compounds described herein can be used for treating or preventing conditions caused by or contributed to by gram positive, gram negative or anaerobic ba...  
WO/2006/050501A3
Novel analogues and derivatives of novobiocin are provided, including compounds having modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds of the present invention are useful as heat shock protein 90 i...  
WO2005107383A8
The present invention relates to the isolation and characterization of nucleotide sequences encoding novel insecticidal proteins secreted into the extracellular space from Bacillus thuringiensis and related strains. The proteins are isol...  
WO/2007/059307A2
Provided is telithromycin which melts at a range of 175 °C to 185 °C. Also provided are solid states of telithromycin and processes for the preparation thereof.  
WO/2007/054296A1
A compound of formula (I) or a pharmaceutically acceptable derivative thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.  
WO/2007/025089A3
The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti- infective, antiproliferative, anti-inflammatory, and prokinetic agents. These compounds ar...  
WO/2007/054295A1
A compound of formula (I) and/or pharmaceutically acceptable derivatives thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.  
WO/2007/014895A3
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diab...  
WO/2007/053642A1
This invention relates to compositions, and methods of use thereof, containing polyphenols such as flavanols, procyanidins and derivatives thereof, for treating and preventing certain tumors/cancers, and more specifically to treating and...  
WO/2007/050375A2
CCR5 antagonists having the following core structure Formula (I) (AA) are claimed, for the treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic der...  
WO/2007/049296A2
The present invention relates to novel substantially amorphous Telithromycin and its process of preparation.  
WO2007025284A8
The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti- infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The compounds hav...  
WO/2007/021721A3
Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with Pseudomonas bacteria. Such infections include Pseudo...  
WO/2005/041859A3
This invention features conjugates, degradable linkers, compositions, methods of synthesis, and applications thereof, including cholesterol, galactosamine, and N-acetyl galactosamine derived conjugates of biologically active compounds, i...  
WO/2007/025098A3
International application No INTERNATIONAL SEARCH REPORT PCT/US2006/03*3170 Box No. IV Text of the abstract (Continuation of item 5 of the first sheet) The present invention provides triazole macrocyclic compounds useful as therapeutic a...  
WO/2007/017898A3
A process of recovery of Pt/C catalyst from the hydrogenation of 6,9-Imino ether is carried out by isolating spent Pt/C by filtration, reactivating the wet spent Pt/C catalyst by treating the spent Pt/C with strong acid like perchloric a...  
WO/2007/044927A2
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO2007003422A9
The present invention relates to macrolide compounds endowed with antiinflammatory activity and more particularly relates to new stable crystalline forms of a macrolide derivative with antiinflammatory activity, processes for the prepara...  
WO/2007/043710A1
Compounds represented by the general formula [I] (wherein each symbol is as defined in the description) or pharmacologically acceptable salts thereof; and pharmaceutical compositions containing the compounds or the salts as the active in...  
WO/2006/035301A3
The present invention provides acylide derivatives, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed to by Gram-positive, Gram-negative or an...  
WO/2005/107383A3
The present invention relates to the isolation and characterization of nucleotide sequences encoding novel insecticidal proteins secreted into the extracellular space from Bacillus thuringiensis and related strains. The proteins are isol...  
WO/2007/039914A2
The present invention relates to novel polymorphs of Telithromycin designated as Form I, II and III and its process for preparation. Also it provides Telithromycin with at least 99% purity.  
WO/2006/056297A3
The invention relates to complexes of specific flavonoid derivatives of formula (I), wherein R1 and R2 are selected among H and OR11, OR11 independently representing OH, straight-chain or branched C1 to C20 alkyloxy groups, straight-chai...  
WO/2007/036951A2
The present invention provides a process for the preparation of 6-O-methylerythromycin A Form II comprising treating 6-O-methylerythromycin A with organic acid selected form trifluoroacetic acid, para-toluene sulphonic acid, oxalic acid ...  
WO/2007/035116A1
A method of localising reproduction assisting hyaluronic acid to reproductive cell surfaces by covalently linking it to lipids is disclosed.  
WO/2006/087644A3
The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4" position, to their pharmaceutically acce...  
WO/2007/029266A2
The invention relates to a process for preparing θ-Deoxo-θa-aza-θa-homoerythromycin A of formula (III), which is an intermediate in the preparation of Azithromycin dihydrate.  
WO/2007/029265A2
The present invention discloses a process for preparing Clarithromycin, comprising selectiviely methylating a 2'I4"-O-bis(trimethylsilyl)erythromycin A 9-[O-(1-methoxy-1- methylethyl)oxime] of formula (II) with methylating agent comprisi...  

Matches 551 - 600 out of 6,631